Package Leaflet: Information for the User
Transtec52.5 micrograms/hour transdermal patch
Buprenorphine
Read all of this leaflet carefully before you start using this medicine, because it contains important information for you.
Contents of the package leaflet
Transtec is a pain reliever (a medicine for pain relief) indicated for the relief of moderate to severe cancer pain and severe pain that does not respond to other types of pain relievers. Transtec acts through the skin. When the transdermal patch is applied to the skin, the active substance buprenorphine passes through the skin into the bloodstream. Buprenorphine is an opioid (a strong pain reliever) that reduces pain by acting on the central nervous system (in specific nerve cells in the spinal cord and brain). The effect of the transdermal patch lasts up to a maximum of four days. Transtec is not suitable for the treatment of acute (short-term) pain.
Do not useTranstec
Transtec should not be used to treat withdrawal syndrome in drug addicts.
Warnings and precautions
Tolerance, dependence, and addiction
This medicine contains buprenorphine, an opioid substance. Repeated use of opioids can reduce the effectiveness of the medicine (your body gets used to the medicine, this is known as tolerance). Repeated use of Transtec can also cause dependence, abuse, and addiction, which can lead to a potentially life-threatening overdose. The risk of side effects may increase with a higher dose and longer duration of use.
Dependence or addiction can make you feel like you no longer have control over the amount of medicine you need to take or how often you need to take it.
The risk of becoming dependent or addicted varies from person to person. You may have a higher risk of becoming dependent or addicted to Transtec if:
If you notice any of the following signs while taking Transtec, it could be a sign that you have become dependent or addicted:
If you notice any of these signs, talk to your doctor to address the most appropriate treatment strategy in your case, including when it is appropriate to stop taking it and how to do it safely (see section 3 "If you stop taking Transtec").
Consult your doctor or pharmacist before starting to use Transtec
The use of these medicines with Transtec can cause serotonin syndrome, a potentially life-threatening disease (see "Using Transtec with other medicines"),
Also, note the following precautions:
Athletes should be warned that this medicine may give a positive result in doping tests.
Respiratory disorders related to sleep
Transtec can cause respiratory disorders related to sleep, such as sleep apnea (pauses in breathing during sleep) and sleep-related hypoxemia (low blood oxygen levels). Symptoms may include pauses in breathing during sleep, nighttime awakenings due to difficulty breathing, difficulty maintaining sleep, or excessive daytime sleepiness. Contact your doctor if you or someone else notices these symptoms. Your doctor may consider a dose reduction.
Children and adolescents
Transtec should not be used in persons under 18 years of age, as there is no experience with its use in this age group to date.
Using Transtec with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Tell your doctor or pharmacist if you are taking:
The concomitant use of Transtec with sedatives or medicines for the treatment of insomnia (such as benzodiazepines) increases the risk of drowsiness, respiratory difficulties (respiratory depression), coma, and can be potentially life-threatening. Due to this, concomitant use should only be considered when other treatment options are not possible. However, if your doctor prescribes Transtec with sedative medicines, they will limit the dose and duration of concomitant treatment. Inform your doctor about all sedative medicines you are taking and strictly follow your doctor's dosage recommendation. It may be helpful to inform your friends and family about the signs and symptoms indicated above. Inform your doctor if you experience any of these symptoms.
Using Transtec with food, drinks, and alcohol
Do not drink alcohol while using Transtec. Alcohol can intensify certain side effects of the transdermal patch and may make you feel unwell.
Drinking grapefruit juice during treatment may intensify the effects of Transtec.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
There is no sufficient experience with the use of Transtec in pregnant women to date. Therefore, Transtec should not be used during pregnancy.
Buprenorphine, the active substance contained in the transdermal patch, passes into breast milk and inhibits milk production. Therefore, Transtec should not be used during breastfeeding.
Driving and using machines
Transtec can make you feel dizzy, drowsy, or have double or blurred vision and can affect your reflexes so that you do not react adequately or quickly enough in case of sudden or unexpected situations.
This applies especially:
If you are affected, you should not drive or operate machinery while using Transtec. This also applies at the end of treatment with Transtec. Do not drive or operate machinery for at least 24 hours after removing the patch.
In case of doubt, consult your doctor or pharmacist.
Follow the administration instructions for this medication exactly as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Before starting treatment and periodically during treatment, your doctor will discuss with you what you can expect from using Transtec, when and for how long you should take it, when to contact your doctor, and when to stop taking it (see also "If you stop treatment with Transtec").
Transtec is available in three doses: Transtec 35 micrograms/hour transdermal patch, Transtec 52.5 micrograms/hour transdermal patch, and Transtec 70 micrograms/hour transdermal patch.
Your doctor has chosen this Transtec patch as the most suitable for you.
During treatment, your doctor may change the transdermal patch you use to a smaller or larger one if necessary.
The recommended dose is:
Adults
Follow these instructions unless your doctor has given you different instructions.
Apply Transtec (as detailed below) and change it after four days, at most. To facilitate use, you can change the patch 2 times a week on fixed days, e.g., "always on Mondays in the morning and Thursdays in the afternoon". To help you remember when to change the transdermal patch, note it on the carton packaging. If your doctor has instructed you to take other pain relievers in addition to the transdermal patch, strictly follow your doctor's instructions; otherwise, you will not fully benefit from treatment with Transtec.
Use in children and adolescents
Transtec should not be used in people under 18 years of age because there is no experience in this age group to date.
Elderly patients
No dose adjustment is required in elderly patients.
Patients with renal impairment/patients undergoing dialysis
In patients with renal impairment and patients undergoing dialysis, no dose adjustment is needed.
Patients with hepatic impairment
In patients with hepatic impairment, the intensity and duration of the action of Transtec may be affected. If you belong to this group of patients, your doctor will monitor you more closely.
Method of administration
Before applying a transdermal patch
|
|
Applying the transdermal patch:
Step 1: Each transdermal patch is sealed in a child-proof envelope. Cut the envelope along the dotted line using scissors. Be careful not to damage the transdermal patches. Remove the transdermal patch. | |
Step 2: The adhesive side of the transdermal patch is covered by a silver protective film. Carefully peel off halfof the film. Try not to touch the adhesive part of the transdermal patch. | |
Step 3: Stick the transdermal patch to the area of skin you have chosen and remove the rest of the film. | |
Step 4: Press the transdermal patch against your skin with the palm of your hand and count slowly to 30. Make sure the entire transdermal patch is in contact with your skin, especially the edges. | |
While wearing the transdermal patch
You can wear the transdermal patch for up to 4 days. If you have applied the transdermal patch correctly, the risk of it coming off is low. You can shower, bathe, or swim while wearing it. However, do not expose the transdermal patch to extreme heat (e.g., sauna, infrared lamps, electric blankets, or hot water bottles).
In the unlikely event that your transdermal patch falls off before you need to change it, do not use the same transdermal patch again. Apply a new one immediately (see "Changing the transdermal patch" below).
Changing the transdermal patch
Duration of treatment
Your doctor will indicate the duration of your treatment with Transtec. Do not stop treatment on your own, as the pain may return and you may feel unwell (see also "If you stop treatment with Transtec").
If you think the effect of Transtec is too strong or too weak, tell your doctor or pharmacist.
If you use more Transtec than you should
If this happens, there may be signs of a buprenorphine overdose. An overdose can intensify the adverse effects of buprenorphine, such as drowsiness, nausea, and vomiting. You may have pinpoint pupils, and your breathing may become slow and weak. You may also experience a cardiovascular collapse.
As soon as you realize you have used more Transtec transdermal patches than you should, remove the excess patches and consult your doctor or pharmacist immediately.
In case of overdose or accidental ingestion, consult the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount used.
If you forget to use Transtec
If you forget an application, apply a new transdermal patch as soon as you remember. This will make you change your routine, e.g., if you normally apply your transdermal patch on Mondays and Thursdays, but you forget and do not apply the new transdermal patch until Wednesday, from then on you will need to change your transdermal patches on Wednesdays and Saturdays. Note the new pair of days on the carton calendar. If you change the transdermal patch too late, the pain may return. In this case, consult your doctor.
Never apply more than one transdermal patch to make up for the one you forgot!
If you stop treatment with Transtec
If you stop or finish treatment with Transtec too early, the pain will return. If you want to stop treatment due to unpleasant side effects, consult your doctor. Your doctor will tell you what you can do and if other medications can be administered.
Some people may have effects after using powerful pain relievers for a long time and stopping them. The risk of having effects after stopping Transtec is very low. However, if you feel agitated, anxious, nervous, or restless, if you are hyperactive, have difficulty sleeping, or have digestive problems, consult your doctor.
If you have any other questions about using this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Side effects are classified as follows:
May affect more than 1 in 10 people |
May affect more than 1 in 100 people |
May affect less than 1 in 100 people |
May affect less than 1 in 1,000 people |
May affect less than 1 in 10,000 people |
Frequency cannot be estimated from the available data |
The following side effects have been reported:
Disorders of the immune system
Very rare: severe allergic reactions (see below)
Metabolic and nutritional disorders
Uncommon: confusion, sleep disorders, restlessness
Rare: illusions and hallucinations, anxiety, nightmares, decreased sexual desire
Very rare: dependence, mood changes
Nervous system disorders
Common: dizziness, headache
Uncommon: various degrees of sedation (serenity), ranging from fatigue to confusion
Rare: difficulty concentrating, speech disorders, confusion, balance disorders, abnormal sensations in the skin (feeling of heat, tingling, or numbness)
Very rare: muscle contraction, taste disorders
Eye disorders
Rare: vision disturbances, blurred vision, eyelid swelling
Very rare: pinpoint pupils
Ear and labyrinth disorders
Very rare: ear pain
Cardiac and vascular disorders
Uncommon: circulatory disorders (such as hypotension or rarely, loss of consciousness due to a drop in blood pressure)
Rare: hot flashes
Respiratory, thoracic, and mediastinal disorders
Common: shortness of breath
Rare: difficulty breathing (respiratory depression)
Very rare: hyperventilation, hiccups
Gastrointestinal disorders
Very common: nausea
Common: vomiting, constipation
Uncommon: dry mouth
Rare: heartburn
Very rare: retching
Skin disorders (usually at the application site)
Very common: erythema, pruritus
Common: skin changes (exanthema, usually due to repeated use), increased sweating
Uncommon: eruptions
Rare: urticarial wheals
Very rare: pustules, vesicles
Frequency not known: contact dermatitis (skin rash with inflammation, which may include a burning sensation), skin discoloration
Urinary and renal disorders
Uncommon: urinary retention (less urine than normal), urination disorders
Reproductive system disorders
Rare: erection difficulties
General disorders
Common: edema (swelling of the legs), fatigue
Uncommon: weakness (exhaustion)
Rare: withdrawal symptoms, administration site reactions
Very rare: chest pain
If you notice any of the above side effects, consult your doctor as soon as possible.
In some cases, late local allergic reactions with marked signs of inflammation occur. In these cases, treatment with Transtec should be discontinued after consulting your doctor.
If you experience inflammation of the hands, feet, knees, face, lips, mouth, or throat, which can cause difficulty swallowing or breathing, urticarial wheals, fainting, yellowing of the skin and eyes (also called jaundice), remove the transdermal patch and consult your doctor or go to the nearest hospital immediately. These may be symptoms of a very rare severe allergic reaction.
Some people may have withdrawal symptoms after using powerful pain relievers for a long time and stopping them. After treatment with Transtec, the risk of experiencing withdrawal symptoms is low. However, if you feel agitated, anxious, nervous, or restless, if you are hyperactive, have difficulty sleeping, or have digestive problems, consult your doctor.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are possible side effects not listed in this leaflet. You can also report them directly through the Spanish Medicines Information System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication in a safe place, protected from others. It can cause serious harm and be fatal if taken accidentally or intentionally by someone who has not been prescribed it.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date shown on the packaging and on the envelope after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Transtec
Transtec 52.5 micrograms/hour transdermal patch | Contains 30 mg of buprenorphine and releases approximately 52.5 micrograms of buprenorphine per hour. The area of the transdermal patch containing the active ingredient is 37.5 cm2. |
Adhesive matrix: (Z)-9-octadecen-1-yl oleate; povidone K90; 4-oxopentanoic acid; poly[acrylic acid-co-butylacrylate-co-(2-ethylhexyl)acrylate-co-vinyl acetate] (5:15:75:5), cross-linked (for the area containing buprenorphine) or non-cross-linked (for the area without buprenorphine); separator film between the adhesive matrices with and without buprenorphine: poly(ethylene terephthalate) film, coating layer: poly(ethylene terephthalate) fabric. Protective release film on the front covering the adhesive matrix containing buprenorphine to be removed before applying the transdermal patch: siliconized poly(ethylene terephthalate) film, coated on one side with aluminum.
Appearance of the product and package contents
Transtec is a flesh-colored transdermal patch with rounded corners, identified as: Transtec 52.5 μg/hour, buprenorphine 30 mg.
Transtec is available in packages containing 3, 4, 5, 6, 8, 10, 11, 12, 16, 18, 20, or 24 transdermal patches, individually sealed in child-proof envelopes.
Only some package sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Grünenthal Pharma, S.A.
Doctor Zamenhof, 36 - 28027 Madrid, Spain
Manufacturer
Grünenthal GmbH
Zieglerstrasse 6 - D - 52078 Aachen, Germany
This medication is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names
Germany Transtec PRO®
Austria Transtec®
Belgium Transtec®
Slovenia Transtec®
Spain Transtec®
Ireland Transtec®
Italy Transtec®
Luxembourg Transtec®
Portugal Transtec®
United Kingdom (Northern Ireland) Transtec®
Date of the last revision of this leaflet: November 2024
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of TRANSTEC 52.5 micrograms/hour transdermal patch in October, 2025 is around 64.57 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.